journal article·2015-09

Synthesis and in vitro bioactivity assessment of injectable bioglass−organic pastes for bone tissue repair

D.U. Tulyaganov, A.A. Reddy, R. Siegel, E. Ionescu, R. Riedel, J.M.F. Ferreira

Ceramics International· Volume 41· Issue 8
Publisher page

Abstract

Abstract The aim of this work was to study the bioactivity of systems based on a clinically tested bioactive glass (BG) particulates (mol%: 4.33 Na 2 O−30.30 CaO−12.99 MgO−45.45 SiO 2 −2.60 P 2 O 5 −4.33 CaF 2 ) and organic carriers. The cohesiveness of injectable bone graft products is of high relevance when filling complex volumetric bone defects. With this motivation behind, BG particulates with mean sizes within 11−14 μm were mixed in different proportions with glycerol (G) and polyethylene glycol (PEG) as organic carriers and the mixtures were fully injectable exhibiting Newtonian flow behaviors. The apatite forming ability was investigated using X-ray diffraction and field emission scanning electron microscopy under secondary electron mode after immersion of samples in simulated body fluid (SBF) for time durations varying between 12 h and 7 days. The results obtained revealed that in spite of the good adhesion of glycerol and PEG carriers to glass particles during preparation stage, they did not hinder the exposure of bioactive glass particulates to the direct contact with SBF solution. The results confirmed the excellent bioactivity in vitro for all compositions expressed by high biomineralization rates with the formation of crystalline hydroxyapatite being identified by XRD after 12 h of immersion in SBF solution.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Bioactive glasses: from macro to nano10.1111/ijag.12028 ↗
2. Adipose-derived mesenchymal stem cells and biomaterials for cartilage tissue engineering10.1016/j.jbspin.2008.07.007 ↗
3. In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for complex defects10.1016/j.actbio.2008.11.030 ↗
4. The safety and efficacy of an injectable bone substitute in dental sockets demonstrated in a human clinical trial10.1016/j.biomaterials.2007.04.006 ↗
5. On the mechanisms of biocompatibility10.1016/j.biomaterials.2008.04.023 ↗
6. The essential materials paradigms for regenerative medicine
7. Fagerlund · 2012
8. Biomaterials
10. A review of the biological response to ionic dissolution products from bioactive glasses and glass–ceramics10.1016/j.biomaterials.2011.01.004 ↗
11. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
12. L.L. Hench, Bioactive Ceramics: Theory and Clinical Applications, Oxford, 1994.10.1016/B978-0-08-042144-5.50005-4 ↗
13. Genetic design of bioactive glass10.1016/j.jeurceramsoc.2008.08.002 ↗
14. A new model formulation of the SiO2–Al2O3–B2O3–MgO–CaO–Na2O–F glass–ceramics10.1016/j.biomaterials.2004.07.030 ↗
15. Formation of hydroxyapatite onto glasses of the CaO–MgO–SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives10.1016/j.biomaterials.2005.10.033 ↗
16. Synthesis, bioactivity and preliminary biocompatibility studies of glasses in the system CaO–MgO–SiO2–Na2O–P2O5–CaF210.1007/s10856-010-4203-5 ↗
17. Biomineralization capability of adherent bio-glass films prepared by magnetron sputtering10.1007/s10856-009-3940-9 ↗
18. Highly adherent bioactive glass thin films synthetized by magnetron sputtering at low temperature10.1007/s10856-011-4441-1 ↗
19. Structural analysis and thermal behavior of diopside–fluorapatite–wollastonite-based glasses and glass–ceramics10.1016/j.actbio.2010.05.019 ↗
20. Synthesis of glass–ceramics in the CaO–MgO–SiO2 system with B2O3, P2O5, Na2O and CaF2 additives10.1016/j.jeurceramsoc.2005.02.009 ↗
21. Structural analysis and devitrification of glasses based on the CaO–MgO–SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives10.1016/j.jnoncrysol.2005.12.003 ↗
22. Synthesis, processing and characterization of a bioactive glass composition for bone regeneration10.1016/j.ceramint.2012.09.011 ↗
23. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering10.1016/j.biomaterials.2006.01.039 ↗
24. Polymer/bioactive glass nanocomposites for biomedical applications: a review10.1016/j.compscitech.2010.06.002 ↗
25. Managing functional constipation in children Canadian Paediatric Society10.1093/pch/16.10.661 ↗
26. Louis · 2012
27. Glycerin, Mayo Foundation for Medical Education and Research, Retrieved 11–17 November 2012.
28. The effect of glycerol, propylene glycol and polyethylene glycol 400 on the partition coefficient of benzophenone-3 (oxybenzone)10.31083/ph.2007.1.6060 ↗
29. C.A. DePaula, Ceramic Composition for Filling Bone Defects, United Sate 8288344 B2, 2012.
30. Premixed calcium silicate cement for endodontic applications10.4161/biom.1.1.16735 ↗
31. Synthesis of biomimetic Ca-hydroxyapatite powders at 37C in synthetic body fluids10.1016/S0142-9612(00)00019-3 ↗
32. Injectability of brushite-forming Mg-substituted and Sr-substituted α-TCP bone cements
33. Effect of particle morphology on the mechanical and thermo-mechanical behavior of polymer composites10.1590/S0100-73862001000100001 ↗
34. Review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2012.08.023 ↗
35. Predicting the bioactivity of glasses using the network connectivity or split network models10.1016/j.jnoncrysol.2011.07.025 ↗
36. Preface
37. NMR investigation of the structure of some bioactive and related glasses10.1016/0022-3093(95)00188-3 ↗
38. Fluoride-containing bioactive glasses: Fluoride loss during melting and ion release in tris buffer solution10.1016/j.jnoncrysol.2011.05.031 ↗
39. Structure, biodegradation behavior and cytotoxicity of alkali-containing alkaline-earth phosphosilicate glasses10.1016/j.msec.2014.08.016 ↗
40. Fluorine-19 magic-angle spinning NMR10.1016/0079-6565(95)01024-6 ↗
42. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers10.1016/j.actbio.2007.01.005 ↗
43. Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites10.1016/j.biomaterials.2005.04.005 ↗
44. Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(ε-caprolactone-co-D,L-lactide) and bioactive glass S53P410.1023/B:JMSM.0000046401.50406.9b ↗
45. Grattan · 1987
46. David W. Grattan, J.C. McCawley, The Chemistry of Polyethylene Glycol, in: Proceedings of the ICOM Waterlogged Wood Working Group conference, 15–18 September 1981, Ottawa, 1982, pp. 279–287.